Pharming Group Nv Stock Technical Analysis
| PHGUF Stock | USD 0.94 0.01 1.08% |
As of the 1st of February, Pharming Group holds the Variance of 5.79, coefficient of variation of 956.02, and Risk Adjusted Performance of 0.0943. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharming Group, as well as the relationship between them. Please check Pharming Group NV market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Pharming Group NV is priced some-what accurately, providing market reflects its current price of 0.94 per share. Given that Pharming Group is a hitting penny stock territory we advise to closely look at its jensen alpha.
Pharming Group Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pharming, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PharmingPharming |
Pharming Group technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Pharming Group NV Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Pharming Group NV volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Pharming Group NV Trend Analysis
Use this graph to draw trend lines for Pharming Group NV. You can use it to identify possible trend reversals for Pharming Group as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Pharming Group price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Pharming Group Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Pharming Group NV applied against its price change over selected period. The best fit line has a slop of 0 , which means Pharming Group NV will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.46, which is the sum of squared deviations for the predicted Pharming Group price change compared to its average price change.About Pharming Group Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pharming Group NV on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pharming Group NV based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Pharming Group NV price pattern first instead of the macroeconomic environment surrounding Pharming Group NV. By analyzing Pharming Group's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pharming Group's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pharming Group specific price patterns or momentum indicators. Please read more on our technical analysis page.
Pharming Group February 1, 2025 Technical Indicators
Most technical analysis of Pharming help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pharming from various momentum indicators to cycle indicators. When you analyze Pharming charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0943 | |||
| Market Risk Adjusted Performance | (0.66) | |||
| Mean Deviation | 0.903 | |||
| Coefficient Of Variation | 956.02 | |||
| Standard Deviation | 2.41 | |||
| Variance | 5.79 | |||
| Information Ratio | 0.0719 | |||
| Jensen Alpha | 0.2663 | |||
| Total Risk Alpha | 0.0446 | |||
| Treynor Ratio | (0.67) | |||
| Maximum Drawdown | 14.97 | |||
| Potential Upside | 2.08 | |||
| Skewness | 2.42 | |||
| Kurtosis | 16.5 |
Complementary Tools for Pharming Pink Sheet analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |